Table 1 Clinicopathologic characteristics of colorectal cancer patients.
From: Genome wide identification of novel DNA methylation driven prognostic markers in colorectal cancer
Characteristics | Cohort (n = 60) |
|---|---|
Age (Median ± SD, years) | 67.5 ± 11.7 |
Gender | |
Female | 29 (48.3%) |
Male | 31 (51.7%) |
Tumor location | |
Colon | 26 (43.3%) |
Rectum | 34 (56.7%) |
Lymphatic invasion | |
Yes | 30 (50%) |
No | 28 (46.7%) |
Unknown | 2 (3.3%) |
Venous invasion | |
Yes | 23 (38.3%) |
No | 33 (55.0%) |
Unknown | 4 (6.7%) |
Peripheral nerve invasion | |
Yes | 28 (46.7%) |
No | 28 (46.7%) |
Unknown | 4 (6.7%) |
Stage | |
I | 8 (13.3%) |
II | 21 (35.0%) |
III | 28 (46.7%) |
IV | 1 (1.7%) |
Unknown | 2 (3.3%) |
MMR status | |
dMMR | 6 (10.0%) |
pMMR | 54 (90.0%) |
Recurrence | |
Yes | 30 (50%) |
No | 30 (50%) |
